Pyridam Farma Tbk PT 

Rp274
+Rp6+2.24% Friday 09:02

统计数据

当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
462.84B
市盈率
1.64
股息收益率
-
股息
-

股息

0%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
N/A
1年增长
N/A

收益

21Jun预期
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q1 2024
-45.55
143.88
333.3
522.73
预期每股收益
N/A
实际每股收益
N/A

人们还关注

此列表基于关注PYFA.JK的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

PT Pyridam Farma Tbk develops, produces, and sells pharmaceuticals, antibiotics, vitamins, supplements, and traditional herbal care products in Indonesia. The company operates in two segments, Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. It offers medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR – extraction kit and extractor machine, speciment bag, sterile container, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; products in the areas of alimentary t. and metabolism, blood and blood forming organs, cardiovascular system, dermatologicals, G.U. system and sex hormones, systemic corticosteroids, systemic antibacterial, sensory organs, as well as musculo-skeletal, nervous, and respiratory systems; and supplements and other preventive consumer health products with energy drinks and healthy ready-to-drink products. In addition, it engages in the research and development on biotechnology, life, and medical science. The company was founded in 1976 and is headquartered in Jakarta, Indonesia.
Show more...
首席执行官
Mr. Yan Gwan Lee
员工
1163
国家
Indonesia
ISIN
ID1000075609

上市公司